- Telehealth Visits
- Insurances Accepted
Margaret A. Tempero, MD
Medical Oncology (Gastrointestinal Cancer)- Telehealth Visits
- Insurances Accepted
Margaret A. Tempero, MD
Medical Oncology (Gastrointestinal Cancer)- Telehealth Visits
- Insurances Accepted
On this page
About me
Dr. Margaret Tempero is a gastrointestinal oncologist and the director of the UCSF Pancreas Center and leader of the Pancreas Cancer Program at the UCSF Helen Diller Family Comprehensive Cancer Center.
In research, Tempero was a pioneer in applying radioactively tagged antibodies for cancer therapy. She has led national research projects on gastrointestinal cancers, including pancreatic cancer.
Tempero has held editorial positions on such prestigious journals as Cancer Research, Journal of Clinical Oncology, Clinical Cancer Research and American Journal of Medicine. She is the Rombauer Family Distinguished Professor in Pancreas Cancer Clinical and Translational Science. Prior to joining UCSF, she was deputy director of the University of Nebraska's cancer center.
Education
Board Certification
- Hematology, American Board of Internal Medicine/Hematology
- Medical Oncology, American Board of Internal Med/Medical Oncology
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Hematology - Oncology, University of Nebraska Medical Center
School
- MD, University of Nebraska Medical Center - Omaha
Academic Title
- Professor
Care Keywords
Services
- Medical Oncology (Gastrointestinal Cancer)
Conditions
- Esophageal Cancer
- Rectal Cancer
Locations
Provider Research Listing
Browse clinical trials and publications by this provider
Clinical trials
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.